JDRF Blog
FDA Approves Medtronic 780G Artificial Pancreas System
FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.
Read More About FDA Approves Medtronic 780G Artificial Pancreas System
JDRF Advocates Unite in D.C. to Fight for the T1D Community
The Federal Government is one of JDRF’s most important partners in advancing research to better treat, prevent, and ultimately cure type 1...
Read More About JDRF Advocates Unite in D.C. to Fight for the T1D Community
Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and Teens
The CLVer study found that newly diagnosed individuals on verapamil were making more insulin one year after diagnosis than those on placebo.
Read More About Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and Teens
FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App
The FDA authorized the Tidepool Loop, an algorithm that could be used to work with commercially available insulin pumps and continuous glucose monitors.
Read More About FDA Authorizes Tidepool Loop, an Automated Insulin Dosing AppRecent Articles
Sign up for our monthly Research Newsletter, The Pipeline, to stay up to date on the latest and greatest in T1D science.
By clicking Sign Up, I agree to the JDRF Privacy Policy. I also agree to receive emails from JDRF and I understand that I may opt out of JDRF subscriptions at any time.